Results 31 to 40 of about 337,094 (289)
Eccentric strength and endurance in patients with unilateral intermittent claudication
OBJECTIVE: To analyze concentric and eccentric strength and endurance in patients with unilateral intermittent claudication. INTRODUCTION: Basic motor tasks are composed of concentric, isometric, and eccentric actions, which are related and contribute to
Márcio Basyches +5 more
doaj +1 more source
Cilostazol for intermittent claudication [PDF]
Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication (exercise-induced lower limb pain relieved by rest). These patients have a three- to six-fold increase in cardiovascular mortality.
Brown, Tamara +5 more
openaire +6 more sources
Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]
Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui +4 more
core +1 more source
Background People with intermittent claudication are at increased risk of death from heart attack and stroke compared to matched controls. Surgery for intermittent claudication is for symptom management and does not reduce the risk of cardiovascular ...
O'Carroll Ronan E +3 more
doaj +1 more source
Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease [PDF]
BackgroundPeripheral arterial disease (PAD) has a significant negative impact on the quality of life of individuals. Understanding the experiences of people living with PAD will be useful in developing comprehensive patient-centred secondary prevention ...
Abaraogu, Ukachukwu Okoroafor +3 more
core +2 more sources
Introduction. There are few studies regarding peripheral artery disease (PAD by intermittent claudication) on adults in Indonesia, including its risk factors.This study aims to determine relationship and comparison of PAD accompanied by intermittent ...
Naldo Sofian +2 more
doaj +1 more source
Transcutaneous calf-muscle electro-stimulation : a prospective treatment for diabetic claudicants? [PDF]
Background: First-line therapy for claudicants with diabetes include supervised exercise programmes to improve walking distance. However, exercise comes with a number of barriers and may be contraindicated in certain conditions. The aim of this study was
Ellul, Christian, Gatt, Alfred
core +1 more source
Background Disease severity and functional impairment in patients with intermittent claudication is usually quantified by the measurement of pain-free walking distance (intermittent claudication distance, ICD) and maximal walking distance (absolute ...
Prins Martin H +5 more
doaj +1 more source
Buflomedil for intermittent claudication [PDF]
Background : Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease.
De Backer, Tine, Vander Stichele, Robert
core +2 more sources
Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study. [PDF]
OBJECTIVES:The aim of this study is to investigate the association between age, gender, body-mass index, smoking behavior, orthopedic comorbidity, neurologic comorbidity, cardiac comorbidity, vascular comorbidity, pulmonic comorbidity, internal ...
Sarah Dörenkamp +4 more
doaj +1 more source

